GlassScriptPhysician profile
Heather Mclendon
NPI 1255974341
$335.47
in general payments reported to CMS, 2019-2025
13 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.51 · 2022: $29.22 · 2023: $53.68 · 2024: $109 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $60.19 | 2023-2024 | Xarelto |
| Mylan Specialty L.P. | $37.57 | 2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.65 | 2025 | Jardiance |
| Abiomed | $26.67 | 2024 | Impella |
| Abbvie INC. | $26.21 | 2025 | |
| Ucb, INC. | $22.51 | 2021 | |
| Genentech USA, INC. | $22.36 | 2023 | Actemra |
| Viatris Specialty LLC | $22.32 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $18.57 | 2025 | Eliquis |
| Vertex Pharmaceuticals Incorporated | $18.00 | 2025 | |
| Tela Bio, INC. | $16.45 | 2022 | |
| Pfizer INC. | $16.20 | 2023 | |
| Sk Life Science, INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Mclendon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.